 |
Mark Westerman
Ph.D.,
President & CEO Chair,
Business Advisory Board,
Executive Chairman, Board of Managers
|
Mark Westerman founded Intrinsic LifeSciences (ILS) in 2006 along with Drs. Tomas Ganz and Elizabeta Nemeth, and has served as President & CEO since. After postdoctoral research at Scripps Institution of Oceanography and as a National Research Council Fellow to NOAA ...Read more |
 |
Tomas GanzPh.D., Co-Founder, Chief Medical Officer, Professor, David Geffen School of Medicine, UCLA |
Tomas Ganz is a co-founder of Intrinsic LifeSciences. He holds a Ph.D. in Applied Physics from the California Institute of Technology and an M.D. from UCLA. Tom trained in Internal Medicine and Pulmonary ...Read more
|
 |
Elizabeta Nemeth
Ph.D.,
Co-Founder,
Chief Scientific Officer,
Assistant Professor, David Geffen School of Medicine, UCLA |
Elizabeta Nemeth is a co-founder of Intrinsic LifeSciences. She holds a Ph.D. in Molecular, Cellular and Neurosciences from the University of Hawaii. Elizabeta joined UCLA in 2002 ...Read more |
 |
John Adamson
M.D.,
University of California San Diego Medical Center
|
John Adamson MD is a Professor of Clinical Medicine in the Department of Medicine at the University of California, San Diego. His long-time interests have been in the regulation of red cell ...Read more |
|
Ph.D., University of California San Diego Division of Biological Sciences
|
Steven P. Briggs is Distinguished Professor of Cell & Developmental Biology at the University of California San Diego. He conducts research on immunity and development in plants and animals. ...Read more |
|
Rob Brown
Ph.D.,
Metabolic Engineering, Synthetic Genomics. Inc. |
Rob Brown PhD is currently Senior Director Synthetic Genomics Inc. where he manages a multifunctional team in the design and development of microbes ...Read more |
 |
Mike Brownstein
M.D., Ph.D.,
National Institutes of Health |
Dr. Brownstein has over thirty years of research experience in the fields of genetics, endocrinology and pharmacology. He earned his bachelor's degree from Columbia University; completed his graduate training at University of Chicago, where ...Read more |
 |
Allen Nissenson
M.D.,
DaVita, Inc., |
Alan Nissenson, MD is Chief Medical Officer of DaVita, Inc. Dr. Nissenson is a graduate of Northwestern University Medical School and spent much of his career at the David Geffen School of Medicine at UCLA where he is still ...Read more |
 |
Michael Pennington
Ph.D.,
Peptides International Inc. |
Michael Pennington joined Peptides International in December 2010 serving as Chief Technology Officer. After doctoral research at University of Florida, he joined the pharmaceutical industry in the Department of Biotechnology ...Read more |
